Three biotech firms sue Columbia
Selected Abstract
Three biotech firms sue Columbia University over gene-splicing patent
00-00-0000 Dateline: BOSTON Three biotechnology companies sued Columbia University, alleging that the school has illegally extended the life of a lucrative patent for gene-splicing technology. Biogen Inc., Genzyme Corp., and Abbott Laboratories filed the lawsuit in U.S. District Court in Boston, ...
July 16, 2003; AP Worldstream
Read the full article with a free-trial membership at HighBeam Research
Related Articles 1.
Three biotech firms sue Columbia University over gene-splicing patent
|